Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

MicroRNAs Link Environmental Exposures to Type 1 Diabetes Risk

A Frontiers in Immunology review links environmental exposures to microRNA changes that may shape immune and beta-cell pathways in type 1 diabetes.

By Dr. A. Nikhil Krishnan, MBBS · Oct 25, 2026 · 6 min read

Endocrinology·BMJ

Testosterone prescribing surge raises NHS monitoring burden

BMJ editorial warns rapid testosterone prescribing may expand treatment beyond confirmed hypogonadism and shift monitoring and adverse-event care…

Oct 25, 2026

Endocrinology·ClinicalTrials

Luseogliflozin Trial Tests Ketosis Risk in Insulin-Treated Type 2 Diabetes

A 12-week randomized trial in insulin-treated type 2 diabetes evaluated luseogliflozin for insulin resistance, glycemic control, and ketone-related…

Oct 25, 2026

Endocrinology·PubMed

PCOS Biomarkers Gain Ground in Multiomics Diagnosis Review

A 2023 review examines multiomics-derived biomarkers for PCOS diagnosis, risk stratification, and future monitoring across complex endocrine pathways.

Oct 24, 2026

Endocrinology·ScienceDaily

MTCH2 protein switch boosts fat burning and blocks fat cell formation

MTCH2 appears to increase fat burning and limit new fat cell formation in human and mouse studies, pointing…

Oct 24, 2026

Endocrinology·Front Immunol

Camera-Based HbA1c Estimation Advances Remote Diabetes Monitoring

A Frontiers study examines camera-based HbA1c estimation with remote photoplethysmography, including development, independent evaluation, and comparator analysis.

Oct 24, 2026

Endocrinology·BMJ

Weight Regain After Stopping Obesity Drugs Reaches 7.2% in Meta-Analysis

A meta-analysis found clinically significant weight regain after stopping obesity medications, with larger rebound after tirzepatide than liraglutide.

Oct 24, 2026

Endocrinology·ClinicalTrials